These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21465530)

  • 1. Sp1 is a transcription repressor to stanniocalcin-1 expression in TSA-treated human colon cancer cells, HT29.
    Law AY; Yeung BH; Ching LY; Wong CK
    J Cell Biochem; 2011 Aug; 112(8):2089-96. PubMed ID: 21465530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Li S; Freeman JW
    Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene.
    Zhang Y; Liao M; Dufau ML
    Mol Cell Biol; 2006 Sep; 26(18):6748-61. PubMed ID: 16943418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells.
    Hsu YF; Sheu JR; Lin CH; Yang DS; Hsiao G; Ou G; Chiu PT; Huang YH; Kuo WH; Hsu MJ
    Biochim Biophys Acta; 2012 Feb; 1820(2):104-15. PubMed ID: 22155142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin structure and expression of the AMPA receptor subunit Glur2 in human glioma cells: major regulatory role of REST and Sp1.
    Ekici M; Keim A; Rössler OG; Hohl M; Thiel G
    J Cell Biochem; 2012 Feb; 113(2):528-43. PubMed ID: 21948504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
    Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
    Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L; Sowa Y; Sakai T; Pardee AB
    Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
    Li H; Wu X
    Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25-dihydroxyvitamin D3 transcriptionally represses p45Skp2 expression via the Sp1 sites in human prostate cancer cells.
    Huang YC; Hung WC
    J Cell Physiol; 2006 Nov; 209(2):363-9. PubMed ID: 16883603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells.
    Kim YH; Park JW; Lee JY; Kwon TK
    Carcinogenesis; 2004 Oct; 25(10):1813-20. PubMed ID: 15142888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
    Sekhavat A; Sun JM; Davie JR
    Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.
    Zelko IN; Folz RJ
    Free Radic Biol Med; 2004 Oct; 37(8):1256-71. PubMed ID: 15451065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of p53 on TSA-induced stanniocalcin 1 expression in human nasopharyngeal carcinoma cells, CNE2.
    Ching LY; Yeung BH; Wong CK
    J Mol Endocrinol; 2012 Jun; 48(3):241-50. PubMed ID: 22493143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.
    Sowa Y; Orita T; Minamikawa-Hiranabe S; Mizuno T; Nomura H; Sakai T
    Cancer Res; 1999 Sep; 59(17):4266-70. PubMed ID: 10485470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichostatin A inhibits TGF-β1 induced in vitro chondrogenesis of hMSCs through Sp1 suppression.
    Wang JP; Wen MH; Chen YT; Lee HH; Chiang ER; Lee YT; Liu CL; Chen TH; Hung SC
    Differentiation; 2011 Feb; 81(2):119-26. PubMed ID: 21074928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors increase human arylamine N-acetyltransferase-1 expression in human tumor cells.
    Paterson S; Sin KL; Tiang JM; Minchin RF; Butcher NJ
    Drug Metab Dispos; 2011 Jan; 39(1):77-82. PubMed ID: 20870783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.